IMMUNOLOGIC STUDIES IN PRIMARY BILIARY CIRRHOSIS
原发性胆汁性肝硬化的免疫学研究
基本信息
- 批准号:3840477
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:B lymphocyte CD4 molecule T lymphocyte antibody formation autoimmune disorder biliary tract disorder biopsy cell population study cellular immunity cellular pathology cytokine helper T lymphocyte human subject human tissue humoral immunity immunochemistry immunoglobulin M immunohematology immunoregulation immunosuppression laboratory mouse leukocyte activation /transformation liver cirrhosis lymphocyte proliferation mixed lymphocyte reaction test monoclonal antibody orphan disease /drug phorbols primary biliary cirrhosis protein kinase C suppressor T lymphocyte tissue /cell culture
项目摘要
Primary biliary cirrhosis (PBC) appears to be a model autoimmune
disease. Abnormal immune mechanisms are being studied in this disease,
but so far a disease-specific immunologic deficit has not been defined
with certainty. To determine whether previously described abnormalities
of lymphocyte function in PBC might be due to altered function of
immunoregulatory T cell subpopulations, phenotypic and functional
characteristics of T cells that have the CD4 antigen detectable (by
monoclonal antibody) on their surface were examined. Patients with PBC
were found to have normal numbers of CD4+, Leu-8+ T cells, but, in
contrast to patients with liver diseases, suppression of immunoglobulin
synthesis and mitogen-stimulated proliferation mediated by this
subpopulation of T cells were defective. These defects in the function
of CD4+, Lei-8+ T cells in patients with PBC were corrected by phorbol
ester suggesting that abnormal function of the biochemical pathway
involving protein kinase C may contribute to the immunological
abnormalities exhibited by patients with PBC. In contrast to control
patients with non-PBC chronic inflammatory liver disease, mRNA for IL-
1,2,4,5 and 6, and TNF-alpha were not detected in liver biopsies from
patients with PBC. mRNA for INF-gamma was detected in 11 of 18 PBC liver
biopsies. While these findings do not exclude a role for cytokines in
the mediation of bile duct lesions in PBC, they suggest that immunologic
injury that is not mediated by cytokines plays a major role in disease
progression in PBC.
原发性胆汁性肝硬变(PBC)似乎是一种自身免疫模型
疾病。人们正在研究这种疾病的异常免疫机制,
但到目前为止,疾病特异性免疫缺陷还没有被定义。
肯定会的。以确定之前描述的异常是否
PBC中淋巴细胞功能的改变可能是由于PBC的功能改变
免疫调节性T细胞亚群,表型和功能
具有可检测到的CD4抗原的T细胞的特征(通过
检测其表面的单抗)。PBC患者
发现有正常数量的CD4+,Leu-8+T细胞,但在
与肝病患者相比,免疫球蛋白抑制
合成及其介导的丝裂原刺激的增殖
T细胞亚群存在缺陷。这些功能上的缺陷
佛波醇对PBC患者外周血中CD4+、Lei-8+T细胞的影响
Ester提示生化途径的异常功能
蛋白激酶C的参与可能有助于免疫学
PBC患者表现出的异常。与对照形成对比
非PBC慢性炎症性肝病患者IL-1mRNA的检测
肝活检组织中未检测到1、2、4、5、6和肿瘤坏死因子-α。
PBC患者。18例PBC肝组织中有11例检测到干扰素-γ的mRNA
活组织检查。虽然这些发现并不排除细胞因子在
胆管病变在PBC中的中介作用,提示免疫学
非细胞因子介导的损伤在疾病中起主要作用
PBC的进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E ANTHONY JONES其他文献
E ANTHONY JONES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E ANTHONY JONES', 18)}}的其他基金
STUDIES OF ALPHA-1-ANTITRYPSIN PHENOTYPES AND METABOLISM
ALPHA-1-抗胰蛋白酶表型和代谢的研究
- 批准号:
3941102 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES RELATING TO THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY & HEPATIC FAILURE
肝性脑病发病机制的相关研究
- 批准号:
3840476 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDIES OF RELATING TO THE PATHOGENESIS OF HEPATIC ENCEPHALOPATHY
肝性脑病发病机制的相关研究
- 批准号:
3918247 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
- 批准号:
3810218 - 财政年份:
- 资助金额:
-- - 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE
针对人 CD4 分子的小鼠单克隆抗体
- 批准号:
3803662 - 财政年份:
- 资助金额:
-- - 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
- 批准号:
3814788 - 财政年份:
- 资助金额:
-- - 项目类别:
MOUSE MONOCLONAL ANTIBODIES AGAINST HUMAN CD4 MOLECULE GENERATE MONOCLONAL ANT
抗人 CD4 分子的小鼠单克隆抗体生成单克隆蚂蚁
- 批准号:
3818867 - 财政年份:
- 资助金额:
-- - 项目类别:














{{item.name}}会员




